ADEMPAS 0.5 mg, film-coated tablet 42 tablets
Active ingredients: Riociguat
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Film-coated tablet42 tabletsorale
Supply disruption
Package details
Original BDPM fields are shown in French.
- Official name
- ADEMPAS 0,5 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) polypropylène aluminium de 42 comprimé(s)
- Marketing authorisation holder
- BAYER AG (ALLEMAGNE)
- Reimbursement according to BDPM
- 30%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 May 2014
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64832942CIP72784891CIP133400927848919Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| RIOCIGUATcomprimé | 0,50 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.